...
首页> 外文期刊>Infectious diseases in obstetrics and gynecology >Promoter Methylation of p16INK4A, hMLH1, and MGMT in Liquid-Based Cervical Cytology Samples Compared with Clinicopathological Findings and HPV Presence
【24h】

Promoter Methylation of p16INK4A, hMLH1, and MGMT in Liquid-Based Cervical Cytology Samples Compared with Clinicopathological Findings and HPV Presence

机译:液基宫颈细胞学样本中p16INK4A,hMLH1和MGMT的启动子甲基化与临床病理结果和HPV存在的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cervical cancer is a common cancer inflicting women worldwide. Even though, persistent infection with oncogenic Human Papillomavirus (HPV) types is considered the most important risk factor for cervical cancer development, less than 5% of women with HPV will eventually develop cervical cancer supporting that other molecular events, like methylation-dependent inactivation of tumor suppressor genes, may cocontribute in cervical carcinogenesis. We analyzed promoter methylation of three candidate genes (p16, MGMT, and hMLH1) in 403 liquid-based cytology samples. Methylation was commonly identified in both benign and pathologic samples and correlated with higher lesion grade determined by cytological, colposcopical, or histological findings, with HPV DNA and mRNA positivity of specific HPV types and p16INK4Aprotein expression. Overall accuracy of methylation is much lower than traditional diagnostic tests ranking it as an ancillary technique with more data needed to identify the exact value of methylation status in cervical carcinogenesis.
机译:宫颈癌是全世界女性普遍罹患的癌症。即使持续感染致癌性人乳头瘤病毒(HPV)类型被认为是宫颈癌发展的最重要危险因素,但只有不到5%的HPV妇女最终会发展出宫颈癌,从而支持其他分子事件,例如甲基化依赖的灭活肿瘤抑制基因可能与宫颈癌的发生有关。我们分析了403个基于液体的细胞学样本中三个候选基因(p16,MGMT和hMLH1)的启动子甲基化。甲基化通常在良性和病理性样品中均被鉴定出,并与由细胞学,阴道镜或组织学检查结果确定的较高病变等级,特定HPV类型的HPV DNA和mRNA阳性以及p16INK4A蛋白表达相关。甲基化的总体准确性远低于传统诊断测试,将其列为辅助技术,需要更多数据来鉴定甲基化状态在宫颈癌变中的确切值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号